American Heart Journal
Volume 152, Issue 3 , Pages 461-468 , September 2006

Sex and classic risk factors after myocardial infarction: a community study

  • Yariv Gerber, PhD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN
    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Susan A. Weston, MS

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Jill M. Killian, BS

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Steven J. Jacobsen, MD, PhD

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Véronique L. Roger, MD, MPH

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN
    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN
    • Corresponding Author InformationReprint requests: Véronique L. Roger, MD, MPH, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Received 6 December 2005 ,Accepted 5 February 2006.

References 

  1. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  2. Chambless LE, Folsom AR, Sharrett AR, et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol. 2003;56:880–890
  3. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003
  4. Gerber Y, Dankner R, Chetrit A, et al. The role of risk factor time trends in the steep decline of CHD mortality between two Israeli cohort studies. Prev Med. 2005;41:85–91
  5. De Bacquer D, De Backer G, Ostor E, et al. Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort. Eur J Cardiovasc Prev Rehabil. 2003;10:289–295
  6. Marchioli R, Avanzini F, Barzi F, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple–risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J. 2001;22:2085–2103
  7. Kaplan RC, Heckbert SR, Furberg CD, et al. Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. J Clin Epidemiol. 2002;55:654–664
  8. Marschner IC, Colquhoun D, Simes RJ, et al. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators. J Am Coll Cardiol. 2001;38:56–63
  9. D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139:272–281
  10. Foody JM, Wang Y, Kiefe CI, et al. Long-term prognostic importance of total cholesterol in elderly survivors of an acute myocardial infarction: the Cooperative Cardiovascular Pilot Project. J Am Geriatr Soc. 2003;51:930–936
  11. Lopez-Jimenez F, Jacobsen SJ, Reeder GS, et al. Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community. Chest. 2004;125:1205–1212
  12. Wilhelmsen L, Pyorala K, Wedel H, et al. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Eur Heart J. 2001;22:1119–1127
  13. Gottlieb S, Boyko V, Zahger D, et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol. 1996;28:1506–1513
  14. Lowe LP, Greenland P, Ruth KJ, et al. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med. 1998;158:2007–2014
  15. Yusuf HR, Giles WH, Croft JB, et al. Impact of multiple risk factor profiles on determining cardiovascular disease risk. Prev Med. 1998;27:1–9
  16. Wilson PW, Kannel WB, Silbershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104–1109
  17. Jousilahti P, Toumilehto J, Vartiainen E, et al. Importance of risk factor clustering in coronary heart disease mortality and incidence in eastern Finland. J Cardiovasc Risk. 1995;2:63–70
  18. Sprecher DL, Pearce GL. How deadly is the “deadly quartet”? A post-CABG evaluation. J Am Coll Cardiol. 2000;36:1159–1165
  19. Vittinghoff E, Shlipak MG, Varosy PD, et al. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med. 2003;138:81–89
  20. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904
  21. Graham MM, Ghali WA, Faris PD, et al. Sex differences in the prognostic importance of diabetes in patients with ischemic heart disease undergoing coronary angiography. Diabetes Care. 2003;26:3142–3147
  22. Benderly M, Behar S, Reicher-Reiss H, et al. Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Epidemiol. 1997;146:153–160
  23. Kornowski R, Goldbourt U, Boyko V, et al. Clinical predictors of reinfarction among men and women after a first myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiology. 1995;86:163–168
  24. Wexler DJ, Grant RW, Meigs JB, et al. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care. 2005;28:514–520
  25. Qureshi AI, Suri MF, Guterman LR, et al. Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2001;161:1621–1628
  26. Chandra NC, Ziegelstein RC, Rogers WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction–I. Arch Intern Med. 1998;158:981–988
  27. Hanratty B, Lawlor DA, Robinson MB, et al. Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study. J Epidemiol Community Health. 2000;54:912–916
  28. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005;353:671–682
  29. Melton LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266–274
  30. Roger VL, Killian J, Henkel M, et al. Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol. 2002;55:593–601
  31. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol. 1996;49:223–233
  32. Prineas R, Crow R, Blackburn H. The Minnesota code manual of electrocardiographic findings. Littleton, Mass: Joen Wright-PSG Inc; 1982;
  33. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med. 2002;136:341–348
  34. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413–2446
  35. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–1057
  36. Perschbacher JM, Reeder GS, Jacobsen SJ, et al. Evidence-based therapies for myocardial infarction: secular trends and determinants of practice in the community. Mayo Clin Proc. 2004;79:983–991
  37. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  38. Jokhadar M, Jacobsen SJ, Reeder GS, et al. Sudden death and recurrent ischemic events after myocardial infarction in the community. Am J Epidemiol. 2004;159:1040–1046
  39. Whisnant JP, Melton LJ, Davis PH, et al. Comparison of case ascertainment by medical record linkage and cohort follow-up to determine incidence rates for transient ischemic attacks and stroke. J Clin Epidemiol. 1990;43:791–797
  40. Bruzzi P, Green SB, Byar DP, et al. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904–914
  41. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891–897
  42. Jha P, Deboer D, Sykora K, et al. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol. 1996;27:1335–1342
  43. Hennekens C, Buring J, Mayrent S. Epidemiology in medicine. Boston (Mass): Little Brown and Co; 1987;
  44. Marroquin OC, Kip KE, Kelley DE, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation. 2004;109:714–721
  45. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med. 2001;135:801–811

 This study was supported by the grants from the Public Health Service and the National Institutes of Health (AR30582, R01 HL 59205 and R01 HL 72435), Bethesda, MD and a Postdoctoral Fellowship Award from the American Heart Association, Greater Midwest Affiliate (0525753Z; Dr Gerber), Dallas, TX.

 The funding sources for this study played no role in the design or conduct of the study; data management and analysis; or manuscript preparation, review, and authorization for submission.

PII: S0002-8703(06)00123-2

doi: 10.1016/j.ahj.2006.02.003

American Heart Journal
Volume 152, Issue 3 , Pages 461-468 , September 2006

Article Tools

* Image Usage & Resolution